Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VYM✓SelectedUSD · VYMGSK vs VYM performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs VYM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+153.3%
VYM return
+485.0%
Excess return
-331.8%
Maximum drawdown
-49.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioVYMExcessAlpha
1D-2.3%-1.1%-1.2%-1.6%
7D-3.0%-1.4%-1.6%-2.2%
30D+0.4%+0.6%-0.2%0.0%
3M-1.2%-2.2%+1.0%+0.2%
6M+0.9%+4.7%-3.8%-2.0%
YTD+4.0%+14.3%-10.3%-4.5%
1Y+7.3%+18.3%-11.0%-3.6%
3Y+57.1%+66.2%-9.1%+12.8%
5Y+43.0%+68.9%-26.0%+0.7%
10Y+103.1%+196.9%-93.9%-3.7%
All+153.3%+485.0%-331.8%-22.7%

Cumulative growth

Daily Returns

Daily percentage return beside VYM.

Daily Out/Under-Performance

Portfolio return minus VYM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VYM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded VYM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling